Rafael Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
13 janv. 2020 09h00 HE
|
Rafael Pharmaceuticals, Inc.
Cranbury, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that...
Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference
13 janv. 2020 08h00 HE
|
Rubius Therapeutics
RTX-240 Investigational New Drug Application for Cancer on File with U.S. Food and Drug Administration Rubius Manufacturing Facility Operational Nine Months Ahead of Schedule and Ready to Supply...
LHC Group to Present at 38th Annual J.P. Morgan Healthcare Conference
09 janv. 2020 07h00 HE
|
LHC Group
LAFAYETTE, La., Jan. 09, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco...
Rubius Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
02 janv. 2020 16h05 HE
|
Rubius Therapeutics
CAMBRIDGE, Mass., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Aptinyx to Present at 38th Annual J.P. Morgan Healthcare Conference
12 déc. 2019 07h07 HE
|
Aptinyx Inc.
EVANSTON, Ill., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Millicom files standard form for notification of major holdings
11 déc. 2019 12h11 HE
|
Millicom International Cellular S.A.
Millicom files standard form for notification of major holdings Luxembourg, December 11, 2019 – Millicom International Cellular SA (“Millicom”) announced today the CSSF regulatory filing of the...
Candel Therapeutics Completes $28.7 Million Series B Financing
04 janv. 2019 14h33 HE
|
Candel Therapeutics
Proceeds to Accelerate Enrollment of Phase 3 Localized Prostate Cancer Clinical Trial and to Advance Late Stage High-Grade Glioma Clinical Program Candel to Expand Clinical Trials in Other...
LHC Group to Present at 37th Annual J.P. Morgan Healthcare Conference
03 janv. 2019 06h30 HE
|
LHC Group
LAFAYETTE, La., Jan. 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco...
BLOK Technologies Provides Update on Greenstream Networks’ Cannabis Industry Technology
17 oct. 2018 09h24 HE
|
BLOK Technologies Inc.
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BLOK Technologies Inc. ("BLOK Tech" or the "Company") (CSE: BLK) (OTC: BLPFF) (FRANKFURT: 2AD) is pleased to provide an update on the...
Jennifer Cherney Joins Greystone as a Managing Director in Seattle
15 oct. 2018 09h00 HE
|
Greystone
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Greystone, a leading commercial real estate lending, investment and advisory company, has hired Jennifer Cherney as a Managing Director as part of its...